Related Experiment Video
Updated: Nov 26, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
The prognostic value of general laboratory testing in patients with COVID-19
Zhihua Lv1, Wei Wang2, Bin Qiao1
1Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Insights
Peripheral blood cell counts and biochemical markers aid in diagnosing COVID-19 and predicting patient outcomes. The neutrophil/lymphocyte ratio (NLR) shows high diagnostic accuracy for coronavirus disease 2019.
Area of Science:
- Clinical Medicine
- Hematology
- Biochemistry
Background:
- Peripheral blood lymphocyte count (LYM) and general biochemical markers are recognized for their diagnostic and prognostic value in COVID-19.
- The utility of other indices in COVID-19 assessment remains less explored.
Purpose of the Study:
- To evaluate the diagnostic and prognostic value of peripheral blood cell counts and general biochemical markers in patients with COVID-19.
- To identify key indicators for distinguishing COVID-19 severity and predicting adverse outcomes.
Main Methods:
- A cohort of 94 COVID-19 patients was classified into moderate, severe, and critical groups.
- Forty healthy individuals served as controls.
- Peripheral blood cell counts and general biochemical analyses were performed and compared across groups.
Main Results:
- Statistically significant differences (p < 0.01) were observed in peripheral blood analyses between COVID-19 patients and healthy controls.
- Significant variations (p < 0.05) in LYM, neutrophil count (Neu), platelet count (PLT), and white blood cell count (WBC) were noted among different COVID-19 severity groups.
- Key biochemical markers including direct bilirubin (DBIL), low-density lipoprotein cholesterol (LDL-Ch), and urea showed significant differences (p < 0.05) across severity levels.
- The neutrophil/lymphocyte ratio (NLR) demonstrated high sensitivity and specificity for COVID-19 diagnosis.
Conclusions:
- Peripheral blood cell counts and biochemical markers are valuable for diagnosing COVID-19 and predicting disease severity and patient prognosis.
- Economical and readily accessible indices are recommended for clinical use in diagnosing and predicting COVID-19 outcomes.
Background:
Lymphocyte count (LYM) of peripheral blood and some indices of general biochemical analysis had diagnostic and prognostic value for coronavirus disease 2019 (COVID-19), and the value of other remaining indices is rare.
Methods:
A total of 94 patients with COVID-19 were enrolled at Renmin Hospital of Wuhan University. According to the severity of COVID-19, the patients were divided into three groups (moderate 49, severe 35, and critical 10), and 40 healthy cases were enrolled in the same period as healthy controls. The diagnostic and prognostic value of indices in peripheral blood cell count and general biochemical analysis was analyzed.
Results:
Compared with healthy cases, the value differences in peripheral blood analysis in patients with COVID-19 were statistically significant (p < 0.01), the differences in LYM, neutrophil count (Neu), platelet count (PLT), and white blood cell count (WBC) were statistically significant among different severity of COVID-19 (p < 0.05). Compared with healthy cases, the differences in general biochemical results in patients with COVID-19 were statistically significant (p < 0.01), the value differences in direct bilirubin (DBIL), low-density lipoprotein cholesterol (LDL-Ch), and nitrogen (urea) were statistically significant among different severity of COVID-19 (p < 0.05). Neutrophil/lymphocyte ratio (NLR) had higher sensitivity and specificity for COVID-19 diagnosis.
Conclusions:
Some indices of peripheral blood cell count and general biochemical analysis were valuable in discriminating COVID-19 and predicting severity and adverse outcome of patients with COVID-19. For clinician, it is better to use more economical and easy-to-get indices to diagnose and predict the prognosis of COVID-19.
Related Concept Videos
Pneumonia III: Complications and Assessment
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Serum Laboratory Studies, Stool Test, Breath Test
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

